Targeting aryl hydrocarbon receptor to prevent cancer in barrier organs is a research paper published in Biochemical Pharmacology (2024). On theSindex it has a DataRank of 0.742. It has been cited 23 times, with 22 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.477
From this paper's citation signal
Citation Network Contribution
0.265
From 15 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 22 citers.
NIH
Grant: R03CA256241
NIH
Grant: R01CA269653
National Institutes of Health
Grant: 1R03CA256241-01
Chemoprevention of lung cancer with the β-blocker carvedilol
National Institutes of Health
Grant: 5R01CA269653-03
Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol
Western University of Health Sciences
National Cancer Institute
FWCI
3.55
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords